PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Chair, Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), School of Life Sciences, University of Nottingham, Nottingham, UK.\', \'Curator, Guide to PHARMACOLOGY (GtoPdb), Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.\', \'Executive Committee, NC-IUPHAR, University of Cambridge, Cambridge, UK.\', \'Principal Investigator, Guide to PHARMACOLOGY (GtoPdb), Executive Committee, NC-IUPHAR, Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.\', \'Database Developer, Guide to PHARMACOLOGY (GtoPdb), Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.\', \'First Vice-President and Chair of Immunopharmacology Section, International Union of Basic and Clinical Pharmacology (IUPHAR), Hebrew University of Jerusalem, Jerusalem, Israel.\', \'University of Cambridge, Cambridge, UK.\', \'Senior Curator, Guide to PHARMACOLOGY (GtoPdb), Executive Committee, NC-IUPHAR, Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.\', \'Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.\', \'TW2Informatics Ltd, Gothenburg, Sweden.\', \'Secretary-General, International Union of Basic and Clinical Pharmacology (IUPHAR) and Spedding Research Solutions SAS, Le Vesinet, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bph.15094
?:doi
?:hasPublicationType
?:journal
  • British journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32358833
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.603
?:rankingScore_hIndex
  • 186
?:title
  • A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all